These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 30419422)

  • 1. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
    Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
    Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
    Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
    BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.
    Xiao S; Liu L; Fang M; Zhou X; Peng X; Long J; Lu X
    Dig Dis Sci; 2015 Apr; 60(4):910-8. PubMed ID: 25362514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
    Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
    Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression.
    Zhan W; Liao X; Wang Y; Li L; Li J; Chen Z; Tian T; He J
    Carcinogenesis; 2019 Jun; 40(4):560-568. PubMed ID: 30403769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
    Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
    Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
    Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
    Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
    Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
    J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
    Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
    Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.
    Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G
    Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
    Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
    Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.